Project Grant HT94252410599
Award Date 8/15/24
Completion Date 8/14/26
Dollars Obligated $249K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Australia
Similar Awards
- The U.S. Department of Defense's Defense Health Agency awarded a $250,000 Project Grant to Yale University under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "EPSTEIN-BARR VIRUS IN PATIENTS WITH NEW-ONSET MULTIPLE SCLEROSIS". The project will run from July 1, 2024 to June 30, 2026. As a prime grantee, Yale University will lead this scientific research effort to advance knowledge about the relationship between Epstein-Barr virus and the...
- This federal Project Grant award of $319,999.00 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research at the University of Maryland, Baltimore on the relationship between cortical lesions, meningeal inflammation, and Epstein-Barr virus infection in multiple sclerosis, as observed using 7-T MRI. The award period runs from November 1, 2024 to October 31, 2026. The research aims to advance understanding of the underlying...
- This Project Grant award of $999,983.00 from the Defense Health Agency supports research by The Leland Stanford Junior University (Stanford University) to analyze Epstein-Barr virus (EBV) genomes, epigenomes, and EBV-dependent B cell proteomes. The goal is to identify fundamental viral triggers of multiple sclerosis (MS). The 3-year project will run from July 1, 2023 to June 30, 2026. This award is funded through the Military Medical Research and Development program (CFDA 12.420), which supports...
- The Defense Health Agency awarded a $744,997 Project Grant to the University of Queensland in Australia under the Military Medical Research and Development program (CFDA 12.420). This grant, titled "DISCOVERING THERAPEUTIC VULNERABILITIES OF CIRCULATING MELANOMA CLUSTERS," provides funding for the university to conduct cutting-edge biomedical research on melanoma from June 1, 2024 through May 31, 2027. The University of Queensland, a leading research institution in Australia, has an...
- Federal Grant Award Summary The University of Queensland has been awarded $1,156,726 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct a three-year research project spanning September 1, 2025, through August 31, 2028. The project, titled "Predicting Early-Stage Melanoma at High Risk of Recurrence Through Multiomics Profiling," focuses on developing innovative diagnostic capabilities to identify melanoma patients at...
- The University of Queensland in Australia was awarded a $296,964 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from March 1, 2023 to February 28, 2025 to investigate epithelial tissue mechanics as a potential new factor in relapse for chronic inflammatory bowel disease. Through this funding, researchers aim to gain insights that could transform healthcare for service members and the public by...
- The University of Queensland in Australia was awarded a $744,744 USD project grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project titled "Understanding the Role of Immature Myeloid Cells in Early Melanoma Establishment" from September 30, 2022 to September 29, 2025. Through this funding, researchers at The University of Queensland will investigate the role of immature myeloid...
- Federal Project Grant Award Summary Brigham & Women's Hospital Inc., Department of Faulkner Pathology, received a $999,999 project grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2025, through July 31, 2028. The funded research initiative, titled "EBV Signatures in Relapsing and Progressive Forms of MS," focuses on identifying and characterizing Epstein-Barr virus (EBV) biomarkers...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The University of Queensland (UQ) a Project Grant totaling $506,785 under the Military Medical Research and Development program (CFDA 12.420) for the period September 1, 2025, through August 31, 2028. The research project, titled "Predicting Early-Stage Melanoma at High Risk of Recurrence Through Multiomics Profiling," focuses on developing advanced diagnostic methodologies to identify melanoma patients at elevated...
- The University of Queensland in Australia was awarded a $520,011 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will support research from August 1, 2022 to July 31, 2025 on a novel mediator of cholangiocarcinoma that has potential as a diagnostic and treatment target. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical...